Drug profile · INN
dosulepin
DOSULEPIN VIATRIS
dosulepin (DOSULEPIN VIATRIS) is a norepinephrine transporter inhibitor. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — dosulepin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
dosulepin (DOSULEPIN VIATRIS) is a norepinephrine transporter inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
INN dosulepin
Brand DOSULEPIN VIATRIS
Mechanism Norepinephrine transporter inhibitor
Target Sodium-dependent noradrenaline transporter
Originator Alphapharm Pty Ltd
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dosulepin?
dosulepin (DOSULEPIN VIATRIS) is a norepinephrine transporter inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for dosulepin?
DOSULEPIN VIATRIS is a marketed brand name for dosulepin. Check FDA Drugs@FDA for the current US label holder and prescribing information.